2011 Homer Smith award: To serve and protect: Classic and novel roles for Na+,K+-adenosine triphosphatase

Journal of the American Society of Nephrology

Volumn 23, Issue 8, 2012, Pages 1283-1290

  Aperia, Anita ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN; DOPAMINE; OUABAIN;

APOPTOSIS; CALCIUM SIGNALING; CELL GROWTH; CELL STIMULATION; ENZYME ACTIVATION; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; INTRACELLULAR SPACE; KIDNEY DISEASE; KIDNEY TUBULE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION; SODIUM ABSORPTION;

EID: 84864851046     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012010102     Document Type: Review

References (82)

1. Kaplan JH: Biochemistry of Na,K-ATPase. Annu Rev Biochem 71: 511-535, 2002
2. Cohen JJ: Relationship between energy requirements for Na+ reabsorption and other renal functions. Kidney Int 29: 32-40, 1986
3. Dunbar LA, Caplan MJ: Ion pumps in polarized cells: sorting and regulation of the Na+, K+-and H+, K+-ATPases. J Biol Chem 276: 29617-29620, 2001
4. Morth JP, Pedersen BP, Buch-Pedersen MJ, Andersen JP, Vilsen B, Palmgren MG, Nissen P: A structural overview of the plasma membrane Na+,K+-ATPase and H+-ATPase ion pumps. Nat Rev Mol Cell Biol 12: 60-70, 2011
5. Ogawa H, Shinoda T, Cornelius F, Toyoshima C: Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci U S A 106: 13742-13747, 2009
6. Pedersen BP, Buch-Pedersen MJ, Morth JP, Palmgren MG, Nissen P: Crystal structure of the plasma membrane proton pump. Nature 450: 1111-1114, 2007
7. 1subunits. J Biol Chem 286: 25801-25812, 2011
8. Geering K: FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol 290: F241-F250, 2006
9. Han F, Bossuyt J, Martin JL, Despa S, Bers DM: Role of phospholemman phosphorylation sites in mediating kinase-dependent regulation of the Na+-K+-ATPase. Am J Physiol Cell Physiol 299: C1363-C1369, 2010
10. Lubarski I, Karlish SJ, Garty H: Structural and functional interactions between FXYD5 and the Na+-K+-ATPase. Am J Physiol Renal Physiol 293: F1818-F1826, 2007
11. Haycock GB, Aperia A: Salt and the newborn kidney. Pediatr Nephrol 5: 65-70, 1991
12. Herin P, Aperia A: Neonatal kidney, fluids, and electrolytes. Curr Opin Pediatr 6: 154-157, 1994
13. Holtbäck U, Aperia AC: Molecular determinants of sodium and water balance during early human development. Semin Neonatol 8: 291-299, 2003
14. Aperia A, Broberger O, Herin P, Thodenius K, Zetterström R: Postnatal control of water and electrolyte homeostasis in pre-term and full-term infants. Acta Paediatr Scand Suppl 305: 61-65, 1983
15. Vanpée M, Ergander U, Herin P, Aperia A: Renal function in sick, very low-birth-weight infants. Acta Paediatr 82: 714-718, 1993
16. Aperia A, Larsson L: Correlation between fluid reabsorption and proximal tubule ultrastructure during development of the rat kidney. Acta Physiol Scand 105: 11-22, 1979
17. Aperia A, Larsson L, Zetterström R: Hormonal induction of Na-K-ATPase in developing proximal tubular cells. Am J Physiol 241: F356-F360, 1981
18. Igarashi Y, Aperia A, Larsson L, Zetterström R: Effect of betamethasone on Na-K-ATPase activity and basal and lateral cellmembranes in proximal tubular cells during early development. Am J Physiol 245: F232-F237, 1983
19. Rane S, Aperia A: Ontogeny of Na-K-ATPase activity in thick ascending limb and of concentrating capacity. Am J Physiol 249: F723-F728, 1985
20. Aperia A, Bertorello A, Seri I: Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252: F39-F45, 1987
21. Cheng XJ, Fisone G, Aizman O, Aizman R, Levenson R, Greengard P, Aperia A: PKA-mediated phosphorylation and inhibition of Na(+)-K(+)-ATPase in response to beta-adrenergic hormone. Am J Physiol 273: C893-C901, 1997
22. Fisone G, Cheng SX, Nairn AC, Czernik AJ, Hemmings HC Jr, Höög JO, Bertorello AM, Kaiser R, Bergman T, Jörnvall H, Aperia A, Greengard P: Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K(+)-ATPase and effects of site-directed mutagenesis. J Biol Chem 269: 9368-9373, 1994
23. Bertorello AM, Aperia A, Walaas SI, Nairn AC, Greengard P: Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme. Proc Natl Acad Sci U S A 88: 11359-11362, 1991
24. Poulsen H, Morth P, Egebjerg J, Nissen P: Phosphorylation of the Na+,K+-ATPase and the H+,K+-ATPase. FEBS Lett 584: 2589-2595, 2010
25. Bertorello A, Aperia A: Na+-K+-ATPase is an effector protein for protein kinase C in renal proximal tubule cells. Am J Physiol 256: F370-F373, 1989
26. Logvinenko NS, Dulubova I, Fedosova N, Larsson SH, Nairn AC, Esmann M, Greengard P, Aperia A: Phosphorylation by protein kinase C of serine-23 of the alpha-1 subunit of rat Na+,K(+)-ATPase affects its conformational equilibrium. Proc Natl Acad Sci U S A 93: 9132-9137, 1996
27. Cheng SX, Aizman O, Nairn AC, Greengard P, Aperia A: [Ca2+]i determines the effects of protein kinases A and C on activity of rat renal Na+,K+-ATPase. J Physiol 518: 37-46, 1999
28. Belusa R, Wang ZM, Matsubara T, Sahlgren B, Dulubova I, Nairn AC, Ruoslahti E, Greengard P, Aperia A: Mutation of the protein kinase C phosphorylation site on rat alpha1 Na+,K+-ATPase alters regulation of intracellular Na+ and pH and in fluences cell shape and adhesiveness. J Biol Chem 272: 20179-20184, 1997
29. Bertorello AM, Hopfield JF, Aperia A, Greengard P: Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature 347: 386-388, 1990
30. Aizman O, Brismar H, Uhlén P, Zettergren E, Levey AI, Forssberg H, Greengard P, Aperia A: Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3: 226-230, 2000
31. Nishi A, Fisone G, Snyder GL, Dulubova I, Aperia A, NairnAC, Greengard P: Regulation of Na+, K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C. J Neurochem 73: 1492-1501, 1999
32. Chibalin AV, Katz AI, Berggren PO, Bertorello AM: Receptor-mediated inhibition of renal Na (+)-K(+)-ATPase is associated with endocytosis of its alpha- and beta-subunits. Am J Physiol 273: C1458-C1465, 1997
33. Salyer S, Lesousky N, Weinman EJ, Clark BJ, Lederer ED, Khundmiri SJ: Dopamine regulation of Na+-K+-ATPase requires the PDZ-2 domain of sodium hydrogen regulatory factor-1 (NHERF-1) in opossum kidney cells. Am J Physiol Cell Physiol 300: C425-C434, 2011
34. Peruchetti DB, Pinheiro AA, Landgraf SS, Wengert M, Takiya CM, Guggino WB, Caruso-Neves C: (Na+ + K+)-ATPase is a target for phosphoinositide 3-kinase/protein kinase B and protein kinase C pathways triggered by albumin. J Biol Chem 286: 45041-45047, 2011
35. Meister B, Fryckstedt J, SchallingM, Cortés R, Hökfelt T, Aperia A, Hemmings HC Jr, Nairn AC, Ehrlich M, Greengard P: Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+, K+-ATPase in renal tubule cells. Proc Natl Acad Sci U S A 86: 8068-8072, 1989
36. Aperia A, Fryckstedt J, Svensson L, Hemmings HC Jr, Nairn AC, Greengard P: Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A 88: 2798-2801, 1991
37. Jose PA, Eisner GM, Felder RA: Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2: 174-183, 2000
38. Bertorello A, Hökfelt T, Goldstein M, Aperia A: Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: Evidence for DA-mediated effect. Am J Physiol 254: F795-F801, 1988
39. Eklöf AC, Holtbäck U, Sundelöf M, Chen S, Aperia A: Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase. Kidney Int 52: 742-747, 1997
40. Banday AA, Lokhandwala MF: Inhibition of natriuretic factors increases blood pressure in rats. Am J Physiol Renal Physiol 297: F397-F402, 2009
41. Aperia A, Holtbäck U, Syrén ML, Svensson LB, Fryckstedt J, Greengard P: Activation/deactivation of renal Na+,K(+)-ATPase: A final common pathway for regulation of natriuresis. FASEB J 8: 436-439, 1994
42. Aperia A, Ibarra F, Svensson LB, Klee C, Greengard P: Calcineurin mediates alpha-adrenergic stimulation of Na+,K(+)-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A 89: 7394-7397, 1992
43. Holtbäck U, Brismar H, DiBona GF, Fu M, Greengard P, Aperia A: Receptor recruitment: A mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci U S A 96: 7271-7275, 1999
44. Ibarra F, Aperia A, Svensson LB, Eklöf AC, Greengard P: Bidirectional regulation of Na+,K(+)-ATPase activity by dopamine and an alpha-adrenergic agonist. Proc Natl Acad Sci U S A 90: 21-24, 1993
45. Khan F, Spicarová Z, Zelenin S, Holtbäck U, Scott L, Aperia A: Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol 295: F1110-F1116, 2008
46. Li D, Scott L, Crambert S, Zelenin S, Eklof AC, Di Ciano L, Ibarra F, Aperia A: Binding of losartan to angiotensin AT1 receptors increases dopamine d1 receptor activation. J Am Soc Nephrol 3: 421-428, 2012
47. Bagrov AY, Shapiro JI, Fedorova OV: Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev 61: 9-38, 2009
48. Schoner W, Scheiner-Bobis G: Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs 7: 173-189, 2007
49. Yatime L, Laursen M, Morth JP, Esmann M, Nissen P, Fedosova NU: Structural insights into the high af finity binding of cardiotonic steroids to the Na+,K+-ATPase. J Struct Biol 174: 296-306, 2011
50. Aperia A: New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J Intern Med 261: 44-52, 2007
51. Pierre SV, Xie Z: The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 46: 303-316, 2006
52. Aizman O, Uhlén P, Lal M, Brismar H, Aperia A: Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc Natl Acad Sci U S A 98: 13420-13424, 2001
53. Miyakawa-Naito A, Uhlén P, Lal M, Aizman O, Mikoshiba K, Brismar H, Zelenin S, Aperia A: Cell signaling microdomain with Na,K-ATPase and inositol 1,4,5-trisphosphate receptor generates calcium oscillations. J Biol Chem 278: 50355-50361, 2003
54. Zhang S, Malmersjö S, Li J, Ando H, Aizman O, Uhlén P, Mikoshiba K, Aperia A: Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer. J Biol Chem 281: 21954-21962, 2006
55. Liu X, Spicarová Z, Rydholm S, Li J, Brismar H, Aperia A: Ankyrin B modulates the function of Na,K-ATPase/inositol 1,4,5-trisphosphate receptor signaling microdomain. J Biol Chem 283: 11461-11468, 2008
56. Liu J, Xie ZJ: The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim Biophys Acta 1802: 1237-1245, 2010
57. De Koninck P, Schulman H: Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 279: 227-230, 1998
58. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517-529, 2003
59. Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI: Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 386: 855-858, 1997
60. Li J, Zelenin S, Aperia A, Aizman O: Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J Am Soc Nephrol 17: 1848-1857, 2006
61. Sarnico I, Lanzillotta A, Boroni F, Benarese M, Alghisi M, Schwaninger M, Inta I, Battistin L, Spano P, Pizzi M: NF-kappaB p50/RelA and c-Rel-containing dimers: Opposite regulators of neuron vulnerability to ischaemia. J Neurochem 108: 475-485, 2009
62. Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A: NF-kappaB in renal inflammation. J Am Soc Nephrol 21: 1254-1262, 2010
63. Dvela M, Rosen H, Ben-Ami HC, Lichtstein D: Endogenous ouabain regulates cell viability. Am J Physiol Cell Physiol 302: C442-C452, 2012
64. Tian J, Li X, Liang M, Liu L, Xie JX, Ye Q, Kometiani P, Tillekeratne M, Jin R, Xie Z: Changes in sodium pump expression dictate the effects of ouabain on cell growth. J Biol Chem 284: 14921-14929, 2009
65. Nguyen AN, Wallace DP, Blanco G: Ouabain binds with high af finity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation. J Am Soc Nephrol 18: 46-57, 2007
66. Abitbol CL, Ingelfinger JR: Nephron mass and cardiovascular and renal disease risks. Semin Nephrol 29: 445-454, 2009
67. Nijland MJ, Ford SP, Nathanielsz PW: Prenatal origins of adult disease. Curr Opin Obstet Gynecol 20: 132-138, 2008
68. Luyckx VA, Brenner BM: The clinical importance of nephron mass. J Am Soc Nephrol 21: 898-910, 2010
69. Welham SJ, Wade A, Woolf AS: Protein restriction in pregnancy is associated with increased apoptosis of mesenchymal cells at the start of rat metanephrogenesis. Kidney Int 61: 1231-1242, 2002
70. Li J, Khodus GR, Kruusmägi M, Kamali-Zare P, Liu XL, Eklöf AC, Zelenin S, Brismar H, Aperia A: Ouabain protects against adverse developmental programming of the kidney. Nat Commun 1: 42, 2010
71. Woods LL,Weeks DA, Rasch R: Programming of adult blood pressure by maternal protein restriction: Role of nephrogenesis. Kidney Int 65: 1339-1348, 2004
72. Schreuder M, Delemarre-van de Waal H, van Wijk A: Consequences of intrauterine growth restriction for the kidney. Kidney Blood Press Res 29: 108-125, 2006
73. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1: 335-347, 1988
74. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE: Human nephron number: implications for health and disease. Pediatr Nephrol 26: 1529-1533, 2011
75. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63: S124-S127, 1997
76. Ritz E, Amann K, Koleganova N, Benz K: Prenatal programming-effects on blood pressure and renal function. Nat Rev Nephrol 7: 137-144, 2011
77. Obrig TG: Escherichia coli shiga toxin mechanisms of action in renal disease. Toxins (Basel) 2: 2769-2794, 2010
78. Lindop GB, Gibson IW, Downie TT, Vass D, Cohen EP: The glomerulo-tubular junction: A target in renal diseases. J Pathol 197: 1-3, 2002
79. Benigni A, Gagliardini E, Remuzzi A, Corna D, Remuzzi G: Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist. Am J Pathol 159: 1743-1750, 2001
80. Chevalier RL, Forbes MS, Thornhill BA: Formation of atubular glomeruli in the developing kidney following chronic urinary tract obstruction. Pediatr Nephrol 26: 1381-1385, 2011
81. Chevalier RL, Forbes MS: Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 19: 197-206, 2008
82. Jacobs BE, Liu Y, Pulina M, Golovina VA, Hamlyn JM: Normal pregnancy: A ouabain resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange and low blood pressure. Am J Physiol Heart Circ Physiol 302: H1317-H1329, 2012